Study design

retrospective

Study time

2003.12-2016.2

Country

United States

Object

patients who underwent RARP for prostate cancer. Inclusion criteria were patients (aged 18–89) with prostate cancer who underwent RARP between December 2003 and February 2016 and who developed a postoperative VTE within 90 days of discharge, defined as clinically significant PE, or DVT diagnosed with either computed tomography or sonography requiring treatment.

Inclusion criteria

Patients who had RARP with no VTE and who did not meet the criteria described for controls were excluded.

Sample size

149

Topic classification

Prediction，Focus on RARP

Keypoint

The Caprini score predicts postoperative venous thromboembolism in patients undergoing RARP.

Year